Imunon, Inc. (IMNN): Total Assets
$12.29M
As of 2025-12-31
$14.99M
As of 2026-06-30
-34.6%
3-year compound annual growth
-20.0%
5-year compound annual growth
-12.9%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $12.29M | +26.5% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $9.72M | -55.7% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $21.92M | -50.2% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $43.98M | -40.6% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $74.05M | +97.3% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $37.53M | -2.0% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $38.28M | -18.3% | 2021-03-19, Balance as of period end |
| 2018-12-31 | $46.86M | -1.4% | 2020-03-25, Balance as of period end |
| 2017-12-31 | $47.51M | +54.0% | 2019-03-29, Balance as of period end |
| 2016-12-31 | $30.85M | -37.1% | 2018-03-27, Balance as of period end |
| 2015-12-31 | $49.03M | -26.5% | 2017-03-24, Balance as of period end |
| 2014-12-31 | $66.69M | +46.0% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $45.67M | +80.1% | 2015-03-12, Balance as of period end |
| 2012-12-31 | $25.36M | -22.3% | 2014-03-13, Balance as of period end |
| 2011-12-31 | $32.65M | n/m | 2013-03-18, Balance as of period end |
| 2010-12-31 | $2.53M | n/a | 2012-03-15, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Imunon, Inc. (IMNN) | 2025-12-31 | $12.29M | +26.5% |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | $12.16M | +493.6% |
| Anebulo Pharmaceuticals, Inc. (ANEB) | 2025-06-30 | $12.15M | +198.2% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $12.00M | +165.1% |
| Nomad Power Solutions, Inc. (NMAD) | 2025-12-31 | $12.73M | n/m |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $12.87M | +43.1% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | $12.96M | +254.9% |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $11.58M | +74.9% |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $11.58M | n/m |
Compare IMNN, TTRX, ANEB, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗